Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How do you unload 25 mil shares when this runs?
Whatever happened to Spongetech? symbol SPNG
Just wish it had more volume.
Nice post! Nope. Your wrong. No RS, that's a hoot, here is why....
Nope. Your wrong. No RS, that's a hoot, here is why....
WANT CELZ FACTS? SEC NOTE 4 - DEBT (included in its entirety herein)
Look for all the bolded text...that will show you the status of the payoffs and the status of the loans that remain. CELZ HAS PAID OFF MORE LOANS THAN WHAT REMAINS. READ FOR YOURSELF.
A few other comments regarding the "future" loans due at the very end of this 10Q Note 4: As of June 30, 2018, future loan maturities are as follows:
For the year ended December 31,
2018: $ 118,434
2019: $ 554,658
Total $ 673,092
Ask yourself, is it possible they could pre-pay any of these future loan maturities? The answer is: YES. Is it possible they already have? The answer is: YES. If PRO-MED (Russian contract deal) paid a $1M exclusive license fee (maybe more?), don't you think they might just pay off all the notes in one fell swoop? THEY ONLY OWE $673,092 and THEY HAVE A MARKET CAP OF ~ 24 MILLION as of this morning (Aug 28th) That's peanuts in debt compared to what this company is trading at RIGHT NOW. NOTHING SCARY ABOUT IT. PERIOD.
CELZ Outstanding Shares in December 2017: 106M Stock was 1.3 pennies
CELZ Outstanding Shares in March 2018: 188M Stock was .0025 pennies
CELZ Outstanding Shares TODAY 2018: 717M Stock today is 3.6 pennies!!! THIS IS 1,703% INCREASE IN PPS SINCE DEC and they have had all this SCARY TOXIC DEBT CONVERT WITH MORE TO COME. Sweet. Keep it coming!
IS IT POSSIBLE FOR OUTSTANDING SHARES TO GO UP AND THE STOCK PRICE WILL TOO? YEEESSSSSSSSSSSSS. DON'T BE FOOLED BY ONE SIDED ARGUMENT.
Big Pharma who owns the BLUE PILL for ED has 5.8 BILLION Outstanding Shares and trades this morning at $41.53. Don't take my word for it: BigBluePillStatsClickHere
FIVE BILLION EIGHT HUNDRED MILLION SHARES OUT. Where are their OS haters? And they are trading in the $40's people ($52B in Revs). CELZ WILL NOT be as big in revenue or OS any time soon BUT, if they do measly $1B in revenue from their GLOBAL CaverStem sales coming soon to a doctor near you!, and they have OS maxed at ~850M with all the SCARY TOXIC notes fully converting, then CELZy could easily trade at $1.17 VERY SOON. Even if this blips up to 1 BILLION OS, it's still a buck a share stock. AND THAT IS ONLY PONDERING ED TREATMENT. What about SPINESTEM? And the other MAJOR PATENTS that have 7 - 20 YEARS of LIFE LEFT? Sheesh. Some just have real SKILLS and they build REAL companies like CELZ. Others just try to scare people for a living and make a pittance. So sad but not my problem! Go CELZ!!!!!
Here be the FACTS since they seem so hard to find:
THE FOLLOWING COMES DIRECTLY FROM THE SEC.GOV ARCHIVES FOR CELZ's June 30, 2018 10Q Reported PERFECTLY ON TIME on August 14, 2018:
NOTE 4 – DEBT
$400,000 Convertible Debenture
On May 2, 2017, the Company entered into a convertible debenture agreement with a third party for an aggregate principal amount of up to $400,000, for which up to $360,000 in proceeds is to be received. On May 2, 2017, the Company received the first tranche of proceeds of $85,000 for which the Company issued a convertible debenture in the face amount of $100,000. During the three and six month period ended June 30, 2018 the Company amortized $54,085 to interest expense. As of June 30, 2018, a discount of $0 remained. During the three and six month periods ended June 30, 2018, the lender converted $54,200 of principal into 23,485,183 shares of common stock. On March 23, 2018 the Company paid the lender $1,000 to extinguish the remaining principal balance. As of June 30, 2018 the Company had fulfilled all the obligations of the debenture.
$115,000 Convertible Note
On April 10, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $115,000, for which $103,250 in proceeds were received on May 5, 2017. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of January 10, 2018. The note holder has notified the company they do not consider the note in default and their intent is to continue converting the remaining principal and accrued interest into common shares. During the three and six month periods ended June 30, 2018, the Company amortized $0 and $4,600 to interest expense respectively. As of June 30, 2018, a discount of $0 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature and the warrants as derivative liabilities, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. During the three and six month periods ended June 30, 2018, the lender converted $70,341 of principal, interest and fees into 80,306,141 common shares $134,127 of principal, interest and fees into 145,929,641 common shares respectively. As of June 30, 2018 the Company had fulfilled all the obligations of the note.
$55,000 Convertible Note
On April 24, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $55,000, for which $47,500 in proceeds were received on May 8, 2017. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of April 24, 2018. During the three and six month periods ended June 30, 2018 the Company amortized $0 and $17,863 to interest expense respectively. As of June 30, 2018, a discount of $0 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature and the warrants as derivative liabilities, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. The warrants were considered derivative liabilities as there are various reset provisions to the exercise price based upon additional issuances of common stock and equivalents. As of June 30, 2018 the Company had fulfilled all the obligations of the note.
$50,000 Secured Convertible Note
On June 26, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $50,000, for which $50,000 in proceeds were received on June 26, 2017. Under the terms of the agreement, the convertible note incurs interest at 12% per annum and matured on December 26, 2017. The convertible note has since been retired through a debt exchange agreement with a third party dated March 8, 2018, see "$60,000 Convertible Note - Global" below.
$50,000 Convertible Note
On July 19, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $50,000, for which $43,000 in proceeds were received on July 25, 2017. Under the terms of the agreement, the convertible note incurs interest at 5% per annum and has a maturity date of July 19, 2018. During the three and six months ended June 30, 2018 the Company amortized $15,068 and $27,397 respectively to interest expense. As of June 30, 2018, a discount of $0 remained.
During the three and six month periods ended June 30, 2018, the lender converted $31,720 of principal, interest and fees into 35,756,381 common shares $54,697 of principal, interest and fees into 56,453,381 common shares respectively. As of June 30, 2018 there were 333,470,447 common shares reserved with our transfer agent. As of June 30, 2018 the Company had fulfilled all the obligations of the note.
-------------------------------------------2018 BEGINS
$30,000 Convertible Note
On January 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $30,000, for which 12,500,000 outstanding warrants from the convertible note dated April 24, 2017 were extinguished. The difference between the convertible note, the conversion feature and the value of the warrants was recorded as a derivative loss. No proceeds were received in conjunction with this note. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of January 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 0 shares reserved with our transfer agent with a potential of up to 1,629,600 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
The Company has the option to redeem the convertible notes at any time within 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.
During the three and six month periods ended June 30, 2018, the lender converted $ 27,744 of principal, interest and fees into 4,533,351 common shares.
$44,000 Convertible Note
On January 17, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $44,000, for which $19,000 in proceeds were received on January 23, 2018 and $19,000 in proceeds were received on February 26, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of January 17, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing the on issuance discount of $4,000, legal fees of $2,000 and the remaining discount of $34,324 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $40,324 to interest expense using the straight-line method over the term of the loan. During the three and six month periods ended June 30, 2018 the Company amortized $32,259 and $40,324 to interest expense respectively. As of June 30, 2018, a discount of $0 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 125,259,293 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
There is no option for the Company to redeem the convertible note prior to maturity.
During the three and six month periods ended June 30, 2018, the lender converted $44,000 of principal, interest and fees into 27,518,485 common shares. As of June 30, 2018 the Company had fulfilled all the obligations of the note.
$12,500 Convertible Note
On January 22, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $12,500, in exchange for the release of reserved shares to the Company. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of January 22, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
The Company has the option to redeem the convertible note within 180 days from the date of issuance at 120% of the principal and interest. After 180 days the right of prepayment expires.
During the three and six month periods ended June 30, 2018, the lender converted $12,925 of principal, interest and fees into 2,111,873 common shares. As of June 30, 2018 the Company had fulfilled all the obligations of the note.
$53,000 Convertible Note
On February 15, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $53,000, for which $50,000 in proceeds were received on February 22, 2018 . Under the terms of the agreement, the convertible note incurs interest at 12% per annum and has a maturity date of February 15, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 61% of the average of the two lowest traded prices of the Company’s common stock during the previous 15 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing the on issuance discount of $3,000 and the remaining discount of $50,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $53,000 to interest expense using the straight-line method over the term of the loan. During the three and six months ended June 30, 2018 the Company amortized $46,611 and $53,000 to interest expense respectively. As of June 30, 2018, a discount of $0 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 0 shares reserved with our transfer agent with a potential of up to 256,031,833 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 22%.
The Company has the option to redeem the convertible notes within 90 days from the date of issuance at 115% of the principal and interest; between 91 and to 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.
On April 26, 2018 the Company retired the note with a payment of $82,084 to the note holder. A derivative liability gain of $279,795 was recorded to reflect the retirement of the derivative liability.
$27,500 Convertible Note
On March 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $27,500, for which proceeds of $23,500 were received on March 9, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is amortizing the discount of $27,500 due to on issuance discount of $4,000 and the recording of a derivative liability as discussed in Note 5. The Company is amortizing the discount of $27,500 to interest expense using the straight-line method over the term of the loan. During the three and six months ended June 30, 2018 the Company amortized $25,842 and $27,500 to interest expense respectively. As of June 30, 2018, a discount of $0 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
The Company has the option to redeem the convertible notes within 30 days from the date of issuance at 115% of the principal and interest; between 31 and to 60 days from the date of issuance at 120% of the principal and interest; between 61 and to 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 120 days from the date of issuance at 130% of the principal and interest; between 121 and to 150 days from the date of issuance at 135% of the principal and interest; between 151 and 180 days from issuance at 140% of principal and interest; and after 180 days the right of prepayment expires.
During the three and six month periods ended June 30, 2018, the lender converted $28,344 of principal, interest and fees into 4,631,346 common shares. As of June 30, 2018 the Company had fulfilled all the obligations of the note.
$60,000 Convertible Note
March 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $60,000, in exchange for the extinguishment of the outstanding principal due on the convertible note dated June 26, 2017, see disclosure above for "$50,000 Secured Convertible Note - WBRE". No proceeds were received in conjunction with the exchange of this convertible note. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. At no additional cost, we issued to the note holder 30,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price. The warrants are exercisable on a cashless basis.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.
At the date of the agreement, the Company determined that the transactions qualified for extinguishment accounting whereby the transaction was accounted for at fair market value with the excess value between the fair value of the old note and new note was accounted for as an extinguishment loss of $154,284.
During the three and six month periods ended June 30, 2018, the lender converted $60,147 of principal, interest and fees into 45,665,203 common shares. As of June 30, 2018 the Company had fulfilled all the obligations of the note.
$115,000 Convertible Note
On March 13, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $115,000, for which $97,250 in proceeds were received on March 19, 2018 . Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of December 13, 2018. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the average of the two lowest traded prices of the Company’s common stock during the previous 25 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to six times the number of common shares the convertible note is convertible into. The Company is amortizing the original issuance discount of $15,000 legal fees of $2,750 and the remaining discount of $97,250 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $115,000 to interest expense using the straight-line method over the term of the loan. During the three and six months ended June 30, 2018 the Company amortized $38,055 and $45,582 to interest expense respectively. As of June 30, 2018, a discount of $69,418 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 500,000,000 shares reserved with our transfer agent with a potential of 114,429,224 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 125% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
The Company has the option to redeem the convertible notes within 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 180 days from the date of issuance at 140% of the principal and interest; and after 180 days the right of prepayment expires.
$48,000 Convertible Note
On March 15, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $48,000, for which $45,600 in proceeds were received on March 20, 2018 . Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 15, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 63% of the average of the two lowest traded prices of the Company’s common stock during the previous 12 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to six times the number of common shares the convertible note is convertible into. The Company is amortizing legal fees of $2,400 and the remaining discount of $45,600 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $48,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended June 30, 2018 the Company amortized $45,896 and $48,000 to interest expense respectively. As of June 30, 2018, a discount of $0 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 0 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
The Company has the option to redeem the convertible notes within 60 days from the date of issuance at 110% of the principal and interest; between 61 and to 120 days from the date of issuance at 124% of the principal and interest; between 121 days and to 180 days from the date of issuance at 138%; and after 180 days the right of prepayment expires.
On April 25, 2018 the Company retired the note with a payment of $60,000 to the note holder. A derivative liability gain of $209,076 was recorded to reflect the retirement of the derivative liability.
$110,000 Convertible Note
On April 3, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $95,000 in proceeds were received on April 3, 2018 . Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 29, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to five times the number of common shares the convertible note is convertible into. The Company is amortizing legal fees of $2,652 and the remaining discount of $107,348 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended June 30, 2018 the Company amortized $26,521 to interest expense. As of June 30, 2018, a discount of $83,479 remained. At no additional cost, we issued to the note holder 11,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price. The warrants are exercisable on a cashless basis.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 118,000,000 shares reserved with our transfer agent with a potential of 92,000,000 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 18%.
The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 140% of the principal and interest. After 180 days the right of prepayment expires.
$110,000 Convertible Note
On April 11, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $100,000 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity 12 months from the effective date of payment. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $10,000 and the remaining discount of $100,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended June 30, 2018 the Company amortized $24,110 to interest expense. As of June 30, 2018, a discount of $85,890 remained. At no additional cost, we issued to the note holder 11,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price. The warrants are exercisable on a cashless basis.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 18,333,333 shares reserved with our transfer agent with a potential of 55,103,411 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 18%.
The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 140% of the principal and interest. After 180 days the right of prepayment expires.
$110,000 Convertible Note
On April 13, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $99,000 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 29, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $10,000, legal fees of $1,000 and the remaining discount of $99,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended June 30, 2018 the Company amortized $24,110 to interest expense. As of June 30, 2018, a discount of $85,890 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 13,000,000 shares reserved with our transfer agent with a potential of 55,103,411 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 22%.
The Company has the option to redeem the convertible notes within 30 days from the date of issuance at 115% of the principal and interest; between 31 and to 60 days from the date of issuance at 120% of the principal and interest; between 61 and to 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 120 days from the date of issuance at 130% of the principal and interest; between 121 and to 150 days from the date of issuance at 135% of the principal and interest; between 151 and to 180 days from the date of issuance at 140% of the principal and interest; and after 180 days the right of prepayment expires.
$108,000 Convertible Note
On May 14, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $108,000, for which $94,960 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of May 14, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $8,000, legal fees of $5,040 and the remaining discount of $94,960 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $108,000 to interest expense using the straight-line method over the term of the loan. During the three and six months ended June 30, 2018 the Company amortized $13,907 to interest expense. As of June 30, 2018, a discount of $94,093 remained.
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of June 30, 2018, there were 35,000,000 shares reserved with our transfer agent with a potential of 53,486,543 being reserved if and when the lender issues a request to our transfer agent.
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
There is no option to pre-pay this note.
$108,000 Note
On June 27, 2018, the Company entered into a note agreement with a third party for an aggregate principal amount of $108,000, for which $100,000 in proceeds were received. Under the terms of the agreement, the note incurs interest at 8% per annum and has a maturity date of June 27, 2019. The Company is amortizing the on-issuance discount of $8,000 to interest expense using the straight-line method over the term of the loan. During the three and six months ended June 30, 2018 the Company amortized $66 to interest expense. As of June 30, 2018, a discount of $7,934 remained.
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
As of June 30, 2018, future loan maturities are as follows:
For the year ended December 31,
2018 118,434
2019 554,658
Total $ 673,092
I predict it will go either up, down or sideways. I am pro CELZ long term.
TruthFairy222. I love that ninja pic. What is that from? Go DRUS
Flippers coming in. Looking for a flip tomorrow.
IT'S A LITTLE OVER BOUGHT. I THINK TOUCHING.055 IS POSSIBLE, BUT WOULDN'T STAY THERE FOR LONG. MEGA LONG TERM POTENTIAL HERE.
Not that BIOAQ is not worth purchasing but, I believe flippers drove the price up near end of day. They'll be out on Monday.
Are you making your dip determination on the inverted hammer with over bought showing on the STO or are there other things you are seeing. Just trying to learn charts.. Thanks
Really good post Chartmaster. Started to sell this morning. Wish I had.
Lesson learned today is YA GOTTA SELL THE EUPHORIA AND BUY THE FEAR!"
Over Bought.. Inverted Hammer. My guess is down. But you never know.
Nice Trade CM
Every time I'm in a penny stock and people start screaming that it's going to a dollar, the company ends up diluting or getting some kind of toxic financing and it falls through the floor. What's different here?
Seems several groups / chat rooms in this flipping.
Again.. Flippers. They'll be out in the morning.
Flippers. They'll be out tomorrow.
Nice video. Tip of the ice berg he says. More states coming. Seems like big potential here.
https://surgeholdings.com/2018/07/30/surge-holdings-inc-announces-agreement-with-oklahoma-grocers-association/
The update that caused the drop this morning seems to be completely manipulation by the company .. possibly to help in their negotiations. Thoughts?
Shoulda sold in the .02s
Looking forward to that breakout.
Down she goes ..again.
What are you thinking on this one Myth?
With all the wonderfullness.. Thought we'd be lifting off .. not going down.
And down it continues to go.
Thanks for the opinion / thoughts.
So I should wait for .10 then right?
Excellent !
Quote:
the uplist will proceed, and the maturation of the company to "the next level" is already well underway. We are now partnered with a Major Studio for distribution; we're Executive Producers / Worldwide Distributors on two CURRENT productions; we have two major titles in theatrical release (Nov. 3 and Dec. 1) and four "genre'" titles for more limited release in the next few months (see below); we have more than doubled the title library for VODWIZ, and partnered with the world's leading digital services operator (Amazon); we have new release DVD and BluRays in the pipeline for February, March, April and May (collectively generating over $4-million in gross shipments), and we are in final documentation of major financing agreements to cover the epic productions of MOTHER GOOSE and MELTDOWN (each of which is trans formative in what they will do for HHSE's profile and revenues).
Haven't been on this board as long as some of you. Has CEO Brian ever discussed or made reference to Not reverse splitting this stock? Just curious. Always seems to be a concern with the pinks.
Here's the message I got in my work email.
beside from having a solid team of business directors, FUAPF:otcpink could develop into a great stock opportunity, due to the progress it's made in the tech company type. Not only has FUAPF features a devotion to pursuing new opportunities at the penny stock company type. And because each man is able to create a pair of skills to otc- FUAPF could grow to be an excellent stock opportunity, due to the progress it's made from the technology company type. Not only has OTC: FUAPF, we will see excellent things from FUAPF-OTC could develop into an excellent stock opportunity, because of the progress it's made in the police company type. Not merely has FUAPF:OTC because we continue to move forward. FUAPF - OTC could become a great stock opportunity, due to the progress it's made in the microcap stock company type. Not merely has OTC- FUAPF has been gaining more attention at the cent stock exchange, and lots of traders are calling otc- FUAPF could grow to be an excellent stock opportunity, because of the progress it has made in the police company type. Not only has (FUAPF:otc) the best thing to hit the company type in a while. We would like you to consider becoming in to FUAPF - OTC could grow to be an excellent stock opportunity, because of the progress it's made from the technology company type. Not just has otcpink: FUAPF, because it could put you to the course toward massive prospective profits. otc- FUAPF could become a great stock opportunity, because of the progress it's made in the small cap stock company type. Not only has FUAPF:otc was generating an attempt to execute its business enterprise design, and it has given it a more solid presence on the marketplace. This plan has made it a viable competition against other programs from the technology company type, and it's a potential to determine increased increase later on. (FUAPF:otcpink) could become an excellent stock opportunity, because of the progress it has made from the penny stock company type. Not merely has otcpink: FUAPF wishes to grow its business by keeping relevant in the current market, also it wants to produce developments which will pave the way for a booming future. By having an excellent team of men and women, OTC- FUAPF could develop into a great stock opportunity, due to the progress it's made in the police company type. Not merely has (FUAPF:otcpink) may have what it takes to come across long-term victory, which is the reason why numerous investors are jumping in.
FUAPF:otcpink - Liquidity & Penny Price Moving Rapidly
Email came from Junina Bellows <CaciliahigyQNlB@gmx.com>
I have no idea who that is. I'm assuming a fake name.
I just got an unsolicited email at work.
Thanks. Just frustrated.
Are you talking about fillings dropping or the share price ?
BLOOD FEAST launches in Beverly Hills - Fans Consume the Red Carpet Smorgasbord!
Greetings HHSE Friends & Followers - The long-awaited theatrical debut of BLOOD FEAST launched this past weekend at the prestigious Laemmle Fine Arts Auditorium in Beverly Hills, CA. The Friday night evening show was preceded by a red-carpet media event, featuring cast, crew and notable film industry celebrities.
HHSE C.E.O Eric Parkinson was joined by BLOOD FEAST producer Dominik Jurczek and director Marcel Walz. The special event was supported by an impressive entourage of national media attendees and specialty horror publications.
The film opened to $4,020 on this single screen - which is more impressive considering that the engagement was a "split" with another movie (SHELTER) in which each of the two films were limited to one screening per day. HHSE feels that the media support for the launch - and the solid box office performance from only three screenings - will position the film for expansion to other theatres and markets over the next four weeks.
Stay tuned for more theatrical release updates this week on BLOOD FEAST, GETTING GRACE and DEATH HOUSE.
SELDOM DOES A 30+ CENT STOCK TRADE AT LESS THAN 2 CENTS. AUDIT, UPLIST, SONY, MOTHER GOOSE, MELTDOWN, ETC, WILL TAKE HHSE PPS TO TRUE VALUE.
HHSE -- NO DILUTION in over 2.5 years!
1). Hannover House has Not Issued any Shares in 2.5-years. See the chart below. For the company's first two years as a public equity, the stock structure was quite stable. For the past 2-1/2 years, the stock structure has also been stable. But in 2013 and 2014, the company got involved in some ugly predatory lender situations, most notably TCA Global and JSJ, which precipitated a rapid growth in share issuances. The business model for both TCA and JSJ - as exercised against HHSE and many other borrowers - is to make repayment with cash as difficult as possible, in order to force a "conversion of the debt" into freely trading shares of the issueer at a dramatic discount-to-market. Such returns grossly exceed the legal usury law limitations in all states, and this general business practice is operating in a legally dubious space. JSJ, for instance, refused to accept repayment from HHSE via a bank wire transfer (including all applicable, legal interest per the note), preferring instead to file a lawsuit (in Texas?!), in order to try to force repayment via shares at 200% or more interest. These predatory lenders generally prey on companies that are unable to defend themselves, and therefore are forced to allow the lenders to squeeze out profits far in excess of lending laws through toxic-conversions; most of the time, these small borrowers are ultimately forced out of business. However, this was not the case with Hannover House - as the company has a operating business that is unaffected by fluctuations of our stock price and not dependent on the issuance of shares for capital. These toxic dilutions from 2013 and 2014 definitely hurt our shareholders, and hurt our "market cap," as demonstrated in the charts. So, the Board voted to cease such forms of borrowing, and as a result, HHSE has not issued any new shares in 2.5-years. Anyone predicting on a chat board or anywhere else that a "big dilution is coming" is mistaken.
HHSE / VODWIZ is going to the Cannes Film Festival and Marche du Filme on May 9th
to not only look for new films that are conducive to the Company's core business plan (of acquiring and releasing quality theatrical films that will work for the Sony Pictures Home Video and Cinedigm models) - but also to present the live (published) BETA site of the VODWIZ portal and to sign up additional program suppliers to participate in that major endeavor. With Amazon Digital providing VODWIZ with backroom operational functions, digital streaming and consumer payment / financial management - (including real-time access to transaction details and payments) - the HHSE / VODWIZ management focus can be on acquiring quality content and building subscribers and per-transaction customers.
VODWIZ can quickly become one of the top streaming portals and OTT Channels in the world, offering (literally) thousands of feature films and hundreds of hours of episodic television programming direct-to-consumers (and via both a per-transaction sale basis or a monthly "all you want to watch" flat subscription fee). With producer sentiments worldwide beginning to sour on the deals now available for content owners from Netflix, Hulu, Amazon Prime and other licensors and portals... the timing to announce a "new V.O.D. storefront" for the placement of film libraries is as perfect as the current moment is for HHSE to file our Form 10 Registration.
Good Word! The Form 10 Registration is important because it's important to a majority of the HHSE shareholders.
THAT SAID, the next questions posed to management often are:
a). Are you proceeding?
b). Is it all happening RIGHT NOW?
c). Is the filing of the Form 10 something that is likely to happen SUPER FAST, but definitely during the current calendar quarter?
The short answer to all three questions is YES. The longer answer is that we have completed our management folders (which are the detailed schedules, summaries and back-ups to the financials), we have completed the new library valuation, and we are days (not weeks) away from presenting the full 2016 and 2017 audit-kit years to our PCAOB auditors.
Good Post Head Clown! THE ABILITY TO LEGITIMATELY ACQUIRE MAJOR VENTURES
Once fully registered, the next obtainable step is to consider another uplist to NASDAQ - as well as to also consider acquiring complementary companies that will work in synchronicity with the HHSE / VODWIZ goals and business model for growth.
PERSONAL BENEFITS TO HHSE MANAGERS
Suppose for a moment that you are one of the principal managers of HHSE, putting in 18+ hours a day for 10+ years and almost zero salary. What is your incentive and upside? Selling a few-million shares every four years for $.01 each? Wouldn't Parkinson and Shefte be WAAAYY better off if they never had to sell ANY of their HHSE shares in order to obtain some of the benefits that could be gleaned from a registered equity? If the registration creates greater access for investors and more become shareholders, the HHSE stock price will appreciate significantly, and with it, the value of the management-owned shares. Which is better to own: 50-million shares at $.015 each or 50-million shares at $.15 each? Clearly, HHSE Managers will benefit alongside all other HHSE Shareholders as the registered equity appreciates to its actual value.
SHARE LIQUIDITY AND EXCHANGE. Yes!
Once registered, the Company's shares can be moved to electronic trading platforms (DWAC / DTC) for simplified deposit of shares and trading eligibility for many larger funds and brokerages.